Text Size

Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment

This study has been withdrawn prior to enrollment.
(difficulty in recruiting parients)
Sponsor:
Information provided by:
The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:
NCT01414829
First received: August 10, 2011
Last updated: December 2, 2012
Last verified: December 2012
History of Changes
  Purpose

Gastric biopsies will be taken to compare different methods of H.pylori disclosure.Standard methods will be compared to culture.


Condition Intervention
Other Diseases or Conditions / Patient
 Procedure: Gastroscopy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment and Comparing of Different Methods for Helicobacter Pylori Disclosure

Resource links provided by NLM:

MedlinePlus related topics: Antibiotics
U.S. FDA Resources

Further study details as provided by The Baruch Padeh Medical Center, Poriya:

Biospecimen Retention:   Samples Without DNA

gastric biopsies


Enrollment: 0
Study Start Date: August 2011
Estimated Study Completion Date: January 2012
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Gastroscopy
    The reason for gastroscopy will be not related to the study
  Eligibility

Ages Eligible for Study:   10 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patient referred for gastroscopy because of clinical reasons

Criteria

Inclusion Criteria:

  • all referred for gastroscopy with clinical or endoscopic signs of peptic disease

Exclusion Criteria:

  • coagulation disorders
  • pregnant women
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01414829

Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Investigators
Principal Investigator: Maya PAritsky, MD Baruch Padeh MC, Israel
  More Information

No publications provided

Responsible Party: Paritsky Maya, Baruch Padeh MC
ClinicalTrials.gov Identifier: NCT01414829     History of Changes
Other Study ID Numbers: paritsky1.ct.il
Study First Received: August 10, 2011
Last Updated: December 2, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by The Baruch Padeh Medical Center, Poriya:
Peptic disease
Helicobacter pylori
Different methods

Additional relevant MeSH terms:
Anti-Bacterial Agents
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 23, 2013